HANOI CPC1 PHARMACEUTICAL JSC CONCLUDES AN IMPRESSIVE JOURNEY AT THE 2025 EXPANDED HUE RHEUMATOLOGY CONFERENCE
HANOI CPC1 PHARMACEUTICAL JSC CONCLUDES AN IMPRESSIVE JOURNEY AT THE 2025 EXPANDED HUE RHEUMATOLOGY CONFERENCE
On July 11, 2025, Ha Noi CPC1 Pharmaceutical JSC, alongside 16 pharmaceutical companies, participated in the 2025 Expanded Hue Rheumatology Conference. The event marked a meaningful step in strengthening connections between Ha Noi CPC1 Pharmaceutical JSC and the rheumatology community in Central Vietnam and beyond.
At the event, the company’s exhibition booth stood out with its well-designed and professionally arranged space, drawing significant interest from doctors, specialists, and speakers. Highlighted products Zoledro, Munora, and Hyaza—from the Musculoskeletal product line—received strong attention and positive feedback, affirming their quality and encouraging further research and innovation.Ha Noi CPC1 Pharmaceutical JSC extends sincere thanks to the Hue Rheumotology Association Organizing Committee for their professionalism and support, helping foster meaningful connections with the medical community. This event reaffirmed the company’s commitment to advancing specialized pharmaceuticals and its long-term support for Vietnam’s healthcare sector.